// App-Quantinova.ai

: CCN3/NOV as a functional driver and prognostic biomarker of prostate cancer bone metastasis.

Researchers

Presenter

  • V?Ronique Ouellet

Principal Investigators

  • Matthew Dankner

  • Laudine Desreumaux-Communal

  • Estelle Schmitt

  • Dru Perkins

  • Matthew G Annis

  • Veronique Barres

  • Christine Caron

  • Anne-Marie Mes-Masson

  • Fred Saad

  • Peter Siegel

Medical Centers

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Montreal University, Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Goodman Research Cancer Centre and McGill University, Montreal, QC, Canada

  • Centre Hospitalier de lUniversite de Montreal/CRCHUM, University of Montreal, Montreal, QC, Canada

  • Goodman Cancer Research Centre, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Urology

Disease

  • Bone metastases

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved